219 related articles for article (PubMed ID: 10081495)
1. Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.
Ueda M; Fujii H; Yoshizawa K; Kumagai K; Ueki K; Terai Y; Yanagihara T; Ueki M
Jpn J Cancer Res; 1998 Dec; 89(12):1334-42. PubMed ID: 10081495
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effects of EGF and TGF-alpha on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in uterine cervical-carcinoma SKG-IIIb cells.
Ueda M; Ueki M; Terai Y; Morimoto A; Fujii H; Yoshizawa K; Yanagihara T
Int J Cancer; 1997 Sep; 72(6):1027-33. PubMed ID: 9378537
[TBL] [Abstract][Full Text] [Related]
3. Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro.
Ueda M; Fujii H; Yoshizawa K; Abe F; Ueki M
Jpn J Cancer Res; 1996 May; 87(5):524-33. PubMed ID: 8641991
[TBL] [Abstract][Full Text] [Related]
4. Effects of EGF and TGF-alpha on invasion and proteinase expression of uterine cervical adenocarcinoma OMC-4 cells.
Ueda M; Fujii H; Yoshizawa K; Terai Y; Kumagai K; Ueki K; Ueki M
Invasion Metastasis; 1998-1999; 18(4):176-83. PubMed ID: 10640903
[TBL] [Abstract][Full Text] [Related]
5. Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells.
Ueda M; Ueki M; Terai Y; Ueki K; Kumagai K; Fujii H; Yoshizawa K; Nakajima M
Gynecol Obstet Invest; 1999; 48(3):221-8. PubMed ID: 10545752
[TBL] [Abstract][Full Text] [Related]
6. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
7. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
[TBL] [Abstract][Full Text] [Related]
8. [In vitro study on the effect of sex steroid and growth factor on growth and laminin, collagen IV, and tissue plasminogen activator production of normal endometrial cells and endometrial cancer cells in culture].
Ueda M; Ueki M; Tsurunaga T; Yamada T; Okamoto Y; Seiki Y; Iwai E; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1219-26. PubMed ID: 1431434
[TBL] [Abstract][Full Text] [Related]
9. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
Ahmed SR; Badger B; Wright C; Manni A
J Steroid Biochem Mol Biol; 1991 Jun; 38(6):687-93. PubMed ID: 2064983
[TBL] [Abstract][Full Text] [Related]
10. Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1.
Zhou L; Leung BS
Biochim Biophys Acta; 1992 Dec; 1180(2):130-6. PubMed ID: 1463764
[TBL] [Abstract][Full Text] [Related]
11. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
12. Induction of thymidine phosphorylase expression and enhancement of Furtulon sensitivity by Taxol in a human ovarian carcinoma cell line.
Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
Anticancer Res; 2003; 23(3B):2665-9. PubMed ID: 12894555
[TBL] [Abstract][Full Text] [Related]
13. Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.
Patterson AV; Zhang H; Moghaddam A; Bicknell R; Talbot DC; Stratford IJ; Harris AL
Br J Cancer; 1995 Sep; 72(3):669-75. PubMed ID: 7669579
[TBL] [Abstract][Full Text] [Related]
14. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
[TBL] [Abstract][Full Text] [Related]
15. Analysis of epidermal growth factor action in human myometrial smooth muscle cells.
Környei JL; Li X; Lei ZM; Rao CV
J Endocrinol; 1995 Aug; 146(2):261-70. PubMed ID: 7561638
[TBL] [Abstract][Full Text] [Related]
16. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
[TBL] [Abstract][Full Text] [Related]
17. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.
Eda H; Fujimoto K; Watanabe S; Ura M; Hino A; Tanaka Y; Wada K; Ishitsuka H
Cancer Chemother Pharmacol; 1993; 32(5):333-8. PubMed ID: 8339382
[TBL] [Abstract][Full Text] [Related]
18. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen, epidermal growth factor, and transforming growth factor-alpha on the growth of human breast epithelial cells in primary culture.
Gabelman BM; Emerman JT
Exp Cell Res; 1992 Jul; 201(1):113-8. PubMed ID: 1612116
[TBL] [Abstract][Full Text] [Related]
20. Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER.
Long BJ; Rose DP
Cancer Lett; 1996 Feb; 99(2):209-15. PubMed ID: 8616826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
